A photo of Tracy Glauser.

Tracy A. Glauser, MD


  • Associate Director, Cincinnati Children's Research Foundation
  • Director, Comprehensive Epilepsy Center
  • Co-Director, Genetic Pharmacology Service
  • Professor, UC Department of Pediatrics

About

Biography

Tracy A. Glauser, MD, is director of the Comprehensive Epilepsy Center and co-director of the Genetic Pharmacology Service at Cincinnati Children’s Hospital Medical Center and professor of pediatrics in the University of Cincinnati College of Medicine. Dr. Glauser received his medical degree, cum laude, from Jefferson Medical College in Philadelphia, PA. He completed his residency in pediatrics at the John Hopkins Hospital in Baltimore, MD, and fellowship in child neurology at The Children’s Hospital of Philadelphia, University of Pennsylvania in Philadelphia, PA. Dr. Glauser completed a National Institute of Neurological Disorders and Stroke research fellowship in pediatric neurology and was a fellow in epilepsy and electroencephalography at St. Louis Children’s Hospital, Washington University School of Medicine in St. Louis, Missouri.

Dr. Glauser has authored and co-authored more than 130 articles and book chapters, been involved with the development of six evidence-based guidelines about epilepsy therapy and given over 150 invited lectures throughout the world. He has been the principal investigator on multiple NIH grants. Currently, Dr. Glauser directs the NIH funded Childhood Absence Epilepsy clinical trial involving 32 pediatric centers around the United States. Dr. Glauser’s fields of expertise are pediatric neurology, pediatric epilepsy, clinical pharmacology and pharmacogenetics.

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

Selected

Development of information sharing in language neocortex in childhood-onset drug-resistant epilepsy. Arya, R; Ervin, B; Wilson, JA; Byars, AW; Rozhkov, L; Buroker, J; Horn, PS; Scholle, C; Fujiwara, H; Greiner, HM; et al. Epilepsia. 2019; 60:393-405.

Selected

Pretreatment behavior and subsequent medication effects in childhood absence epilepsy. Shinnar, RC; Shinnar, S; Cnaan, A; Clark, P; Dlugos, D; Hirtz, DG; Hu, F; Liu, C; Masur, D; Weiss, EF; et al. Neurology. 2017; 89:1698-1706.

Selected

Pretreatment seizure semiology in childhood absence epilepsy. Kessler, SK; Shinnar, S; Cnaan, A; Dlugos, D; Conry, J; Hirtz, DG; Hu, F; Liu, C; Mizrahi, EM; Moshe, SL; et al. Neurology. 2017; 89:673-679.

Selected

Pharmacogenetics of antiepileptic drug efficacy in childhood absence epilepsy. Glauser, TA; Holland, K; O'Brien, VP; Keddache, M; Martin, LJ; Clark, PO; Cnaan, A; Dlugos, D; Hirtz, DG; Shinnar, S; et al. Annals of Neurology. 2017; 81:444-453.

Selected

Second monotherapy in childhood absence epilepsy. Cnaan, A; Shinnar, S; Arya, R; Adamson, PC; Clark, PO; Dlugos, D; Hirtz, DG; Masur, D; Glauser, TA; Study, CA E. Neurology. 2017; 88:182-190.

Selected

Long-term outcomes of generalized tonic-clonic seizures in a childhood absence epilepsy trial. Shinnar, S; Cnaan, A; Hu, F; Clark, P; Dlugos, D; Hirtz, DG; Masur, D; Mizrahi, EM; Moshe, SL; Glauser, TA; et al. Neurology. 2015; 85:1108-1114.

Selected

Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months. Glauser, TA; Cnaan, A; Shinnar, S; Hirtz, DG; Dlugos, D; Masur, D; Clark, PO; Adamson, PC; Study, CA E. Epilepsia. 2013; 54:141-155.

Selected

Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. Glauser, TA; Cnaan, A; Shinnar, S; Hirtz, DG; Dlugos, D; Masur, D; Clark, PO; Capparelli, EV; Adamson, PC; Study, CA E. New England Journal of Medicine. 2010; 362:790-799.

Seizure clusters: Practical aspects and clinical strategies to care for patients in the community. Penovich, PE; Glauser, T. Epilepsia. 2022; 63 Suppl 1:S3-S5.

Neuronal Circuits Supporting Development of Visual Naming Revealed by Intracranial Coherence Modulations. Arya, R; Ervin, B; Buroker, J; Greiner, HM; Byars, AW; Rozhkov, L; Skoch, J; Horn, PS; Frink, C; Scholle, C; et al. Frontiers in Neuroscience. 2022; 16.

From the Blog


PEDSnet Report Details How COVID-19 Pandemic Has Affected Children
Infectious Diseases and Vaccines

PEDSnet Report Details How COVID-19 Pandemic Has Affected Children

Tracy A. Glauser, MD, Nathan Pajor, MD ...11/23/2020

GRIN Network Shows Early Success in Big-Data Sharing
Big Data and Analytics

GRIN Network Shows Early Success in Big-Data Sharing

Tracy A. Glauser, MD9/5/2019

Reimagining How We Think About Our Brains
Mind Brain Behavior

Reimagining How We Think About Our Brains

Tracy A. Glauser, MD, Lori J. Stark, PhD, ABPP7/3/2019

Teaming Up to Solve a Headache About Headaches
Mind Brain Behavior

Teaming Up to Solve a Headache About Headaches

Tracy A. Glauser, MD, Scott W. Powers, PhD, ABPP, FAHS ...7/3/2019

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey